Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2002 3
2003 3
2004 1
2005 4
2006 1
2007 1
2008 2
2010 1
2011 2
2012 3
2013 2
2014 1
2015 1
2019 1
2020 2
2021 2
2022 2
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.
Mekinian A, Zhao LP, Chevret S, Desseaux K, Pascal L, Comont T, Maria A, Peterlin P, Terriou L, D'Aveni Piney M, Gourin MP, Vey N, Rauzy OB, Grobost V, Bezanahary H, Dimicoli-Salazar S, Banos A, Wickenhauser S, De Renzis B, Durot E, Natarajan-Amé S, Voillat L, Chermat F, Lemaire K, Jachiet V, Himberlin C, Thépot S, Diaz JMT, Frenzel L, Gyan E, Denis G, Hirsch P, Kosmider O, Ades L, Fain O, Fenaux P. Mekinian A, et al. Among authors: natarajan ame s. Leukemia. 2022 Nov;36(11):2739-2742. doi: 10.1038/s41375-022-01698-8. Epub 2022 Sep 14. Leukemia. 2022. PMID: 36104395 Clinical Trial. No abstract available.
Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib.
Levêque D, Becker G, Bilger K, Natarajan-Amé S. Levêque D, et al. Among authors: natarajan ame s. Clin Pharmacokinet. 2020 Jul;59(7):849-856. doi: 10.1007/s40262-020-00872-4. Clin Pharmacokinet. 2020. PMID: 32112275 Review.
Multiple vertebral osteonecrosis.
Javier RM, Moser T, Dietemann JL, Sparsa L, Natarajan-Ame S, Chenard MP, Kuntz JL. Javier RM, et al. Among authors: natarajan ame s. Joint Bone Spine. 2008 May;75(3):341-4. doi: 10.1016/j.jbspin.2007.05.010. Epub 2007 Aug 31. Joint Bone Spine. 2008. PMID: 17921020
Invasive pulmonary aspergillosis.
Herbrecht R, Natarajan-Amé S, Letscher-Bru V, Canuet M. Herbrecht R, et al. Among authors: natarajan ame s. Semin Respir Crit Care Med. 2004 Apr;25(2):191-202. doi: 10.1055/s-2004-824903. Semin Respir Crit Care Med. 2004. PMID: 16088462
The lipid formulations of amphotericin B.
Herbrecht R, Natarajan-Amé S, Nivoix Y, Letscher-Bru V. Herbrecht R, et al. Among authors: natarajan ame s. Expert Opin Pharmacother. 2003 Aug;4(8):1277-87. doi: 10.1517/14656566.4.8.1277. Expert Opin Pharmacother. 2003. PMID: 12877636 Review.
Management of systemic fungal infections: alternatives to itraconazole.
Herbrecht R, Nivoix Y, Fohrer C, Natarajan-Amé S, Letscher-Bru V. Herbrecht R, et al. Among authors: natarajan ame s. J Antimicrob Chemother. 2005 Sep;56 Suppl 1:i39-i48. doi: 10.1093/jac/dki223. J Antimicrob Chemother. 2005. PMID: 16120633 Review.
Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases.
Jachiet V, Ricard L, Hirsch P, Malard F, Pascal L, Beyne-Rauzy O, Peterlin P, Maria ATJ, Vey N, D'Aveni M, Gourin MP, Dimicoli-Salazar S, Banos A, Wickenhauser S, Terriou L, De Renzis B, Durot E, Natarajan-Ame S, Vekhoff A, Voillat L, Park S, Vinit J, Dieval C, Dellal A, Grobost V, Willems L, Rossignol J, Solary E, Kosmider O, Dulphy N, Zhao LP, Adès L, Fenaux P, Fain O, Mohty M, Gaugler B, Mekinian A; MINHEMON: French Network of dysimmune disorders associated with hemopathies. Jachiet V, et al. Among authors: natarajan ame s. Clin Exp Med. 2023 Jul;23(3):803-813. doi: 10.1007/s10238-022-00866-5. Epub 2022 Aug 11. Clin Exp Med. 2023. PMID: 35953763
Fatal Aspergillus fumigatus Myositis in an immunocompetent patient.
Javier RM, Sibilia J, Lugger AS, Natarajan-Ame S, Kuntz JL, Herbrecht R. Javier RM, et al. Among authors: natarajan ame s. Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):810-3. doi: 10.1007/s100960100607. Eur J Clin Microbiol Infect Dis. 2001. PMID: 11783699 Review.
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.
Vannucchi AM, Kantarjian HM, Kiladjian JJ, Gotlib J, Cervantes F, Mesa RA, Sarlis NJ, Peng W, Sandor V, Gopalakrishna P, Hmissi A, Stalbovskaya V, Gupta V, Harrison C, Verstovsek S; COMFORT Investigators. Vannucchi AM, et al. Haematologica. 2015 Sep;100(9):1139-45. doi: 10.3324/haematol.2014.119545. Epub 2015 Jun 11. Haematologica. 2015. PMID: 26069290 Free PMC article. Clinical Trial.
31 results